The Alzheimer's Biomarker Consortium‐Down Syndrome: Rationale and methodology

INTRODUCTION: Adults with Down syndrome (DS) are at exceptionally high risk for Alzheimer's disease (AD), with virtually all individuals developing key neuropathological features by age 40. Identifying biomarkers of AD progression in DS can provide valuable insights into pathogenesis and sugges...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Alzheimers Dement (Amst)
Autors principals: Handen, Benjamin L., Lott, Ira T., Christian, Bradley T., Schupf, Nicole, OBryant, Sid, Mapstone, Mark, Fagan, Anne M., Lee, Joseph H., Tudorascu, Dana, Wang, Mei‐Cheng, Head, Elizabeth, Klunk, William, Ances, Beau, Lai, Florence, Zaman, Shahid, Krinsky‐McHale, Sharon, Brickman, Adam M., Rosas, H. Diana, Cohen, Annie, Andrews, Howard, Hartley, Sigan, Silverman, Wayne
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Review Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7396809/
https://ncbi.nlm.nih.gov/pubmed/32775597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/dad2.12065
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars